Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of Narrowband UVB versus methotrexate on serum TWEAK levels in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Narrowband UVB

Snippet

Sponsor: Aswan University Hospital | Conditions: Psoriasis | Phase 4 | Status: UNKNOWN